A&G Pharmaceutical is a pioneering theranostics company that focuses on developing monoclonal antibodies targeting cancer-specific markers for both therapeutic and diagnostic purposes. The company's innovative approach to utilizing its patented growth factor, GP88, has led to the advancement of diagnostic test kits specifically designed for the early detection, diagnosis, and treatment of breast cancer. In addition to its diagnostic products, A&G's therapeutic division is dedicated to developing anti-GP88 monoclonal antibody treatments for cancer. The company generates revenue through its customized antibody service, which expedites the creation of novel antibody therapeutics for leading pharmaceutical and biotechnology firms, as well as federal laboratories. A&G Pharmaceutical was founded in 2000 and has successfully raised $3.5 million in equity capital. Based in Columbia, Maryland, the company received a $100.00K Venture Round investment on 27 April 2010.
A&G Pharmaceutical, Inc.
Pioneering the future of cancer treatment and diagnostics through innovative monoclonal antibody development.
Columbia, United States
8 employees
Venture round
Total: $2.10M
Biotechnology, Health and Wellness +1
General Information
Columbia, United States
BounceWatch is an independent company data service, not affiliated with A&G Pharmaceutical, Inc.. To contact A&G Pharmaceutical, Inc., visit agpharma.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does A&G Pharmaceutical, Inc. compare?
A PDF of A&G Pharmaceutical, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting A&G Pharmaceutical, Inc. soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About A&G Pharmaceutical, Inc.
Business keywords: monoclonal antibodies, cancer treatment, diagnostics, theranostics, drug development, cancer-specific markers, breast cancer, GP88 growth factor, equity capital, scientific research, biopharmaceuticals
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $100.00K | - |
|
27 Apr 2010 |
| Series A | $2.00M | 3 |
|
08 Sep 2005 |
A&G Pharmaceutical, Inc. Alternatives & Competitors
View All Alternatives
Committed to being a place where our people and science thrive.
An innovative biomarker-guided precision medicine solution for patients in acute care with sepsis an...
We are a biopharmaceutical company committed to the discovery and development of mono- and combinati...
FAQ About A&G Pharmaceutical, Inc.
Source: BounceWatch company record for A&G Pharmaceutical, Inc., https://bouncewatch.com/company/ag-pharmaceutical, updated 27 October 2024. When citing, please name BounceWatch and link this page.
